Valuation: Kobayashi Pharmaceutical Co., Ltd.

Market Cap 437B 2.75B 2.42B 2.28B 2.08B 3.89B 264B 3.92B 27.38B 10.61B 134B 10.33B 10.11B P/E 2026 *
42.3x
P/E 2027 * 32.5x
Enterprise Value 375B 2.36B 2.08B 1.96B 1.78B 3.34B 226B 3.36B 23.48B 9.1B 115B 8.86B 8.67B EV / Sales 2026 *
2.18x
EV / Sales 2027 * 2.05x
Free-Float
64.44%
Yield 2026 *
1.8%
Yield 2027 * 1.86%
1 day+0.43%
1 week+1.52%
Current month+3.43%
1 month+4.46%
3 months+9.59%
6 months+4.92%
Current year+8.42%
1 week 5,817
Extreme 5817
5,901
1 month 5,640
Extreme 5640
5,922
Current year 5,251
Extreme 5251
6,140
1 year 5,030
Extreme 5030
6,140
3 years 4,700
Extreme 4700
7,050
5 years 4,700
Extreme 4700
10,470
10 years 4,700
Extreme 4700
13,120
Manager TitleAgeSince
Director of Finance/CFO - -
President 62 2025-02-28
Chief Tech/Sci/R&D Officer 51 2020-06-30
Director TitleAgeSince
Director/Board Member 55 2004-05-31
Director/Board Member 69 2022-02-28
Chairman 72 2025-03-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%+1.52%+8.52%-10.36% 2.75B
-1.16%-0.91%-4.47%-3.89% 342B
+0.67%+1.48%-6.03%+1.68% 134B
-0.71%-1.95%+6.45%+17.76% 68.5B
-0.85%-1.45%-23.34%-22.11% 47.83B
-3.50%-0.24%+8.72%-35.39% 35.76B
-0.34%-1.23%+2.15%-14.31% 33.94B
+0.20%+1.43%+6.48%+28.86% 19.87B
+2.98%+4.69%-12.69%-37.93% 18.86B
-0.88%-1.25%+8.09%+11.86% 17.97B
Average -0.14%+0.72%-0.61%-6.38% 72.13B
Weighted average by Cap. +0.16%+0.35%-3.56%-3.68%

Financials

2026 *2027 *
Net sales 172B 1.08B 952M 897M 819M 1.53B 104B 1.54B 10.77B 4.17B 52.87B 4.06B 3.98B 179B 1.13B 993M 936M 854M 1.6B 108B 1.61B 11.23B 4.35B 55.14B 4.24B 4.15B
Net income 10.44B 65.66M 57.75M 54.44M 49.67M 92.89M 6.3B 93.62M 653M 253M 3.21B 247M 241M 13.55B 85.26M 74.99M 70.7M 64.5M 121M 8.18B 122M 848M 329M 4.17B 320M 313M
Net Debt -62.41B -393M -345M -326M -297M -555M -37.69B -560M -3.91B -1.51B -19.18B -1.47B -1.44B -70.02B -440M -387M -365M -333M -623M -42.28B -628M -4.38B -1.7B -21.52B -1.65B -1.62B
Logo Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of healthcare products, daily necessities, and products such as heat packs. The Company operates through two segments including domestic and international. Healthcare products include anmerutsu, eyebon, inochinohaha, naishitoru, and oral hygiene products. Daily necessities include air fresheners/deodorizers, sundries, and food products. The Company also engages in transportation services, the manufacture and sale of synthetic resin containers, real estate management, and advertising planning and production.
Employees
3,731
Date Price Change Volume
26-09-24 JP¥5,885.00 +0.43% 190,500
26-09-18 JP¥5,860.00 -0.03% 218,200
26-09-17 JP¥5,862.00 +1.12% 157,400
26-09-16 JP¥5,797.00 -0.29% 149,600
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
5,885.00JPY
Average target price
5,521.25JPY
Spread / Average Target
-6.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4967 Stock